| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:846-854.)
© 2007 American Heart Association, Inc.
Cardiovascular Disease in Women |
From the Department of Medicine, George Washington University, Washington, DC (J.H.); Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill (G.H.); Fred Hutchinson Cancer Research Center, Seattle, Wash (H.R.); Department of Family and Preventive Medicine, University of California at San Diego, San Diego (M.A.); Departments of Medicine (N.C.D., P.G.) and Preventive Medicine (P.G.), Northwestern University, Chicago, Ill; Department of Epidemiology, University of Washington, Seattle (S.R.H.); Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis (K.C.J.); Division of Preventive Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Mass (J.E.M.); Kaiser Permanente, Oakland, Calif (S.S.); and University at Buffalo School of Public Health and Health Professions, Buffalo, NY (M.T.).
Correspondence to Judith Hsia, MD, 2150 Pennsylvania Ave, NW No. 4414, Washington, DC 20037. E-mail jhsia{at}mfa.gwu.edu
Received November 2, 2006; accepted December 14, 2006.
Background Individuals with vascular or valvular calcification are at increased risk for coronary events, but the relationship between calcium consumption and cardiovascular events is uncertain. We evaluated the risk of coronary and cerebrovascular events in the Womens Health Initiative randomized trial of calcium plus vitamin D supplementation.
Methods and Results We randomized 36 282 postmenopausal women 50 to 79 years of age at 40 clinical sites to calcium carbonate 500 mg with vitamin D 200 IU twice daily or to placebo. Cardiovascular disease was a prespecified secondary efficacy outcome. During 7 years of follow-up, myocardial infarction or coronary heart disease death was confirmed for 499 women assigned to calcium/vitamin D and 475 women assigned to placebo (hazard ratio, 1.04; 95% confidence interval, 0.92 to 1.18). Stroke was confirmed among 362 women assigned to calcium/vitamin D and 377 assigned to placebo (hazard ratio, 0.95; 95% confidence interval, 0.82 to 1.10). In subgroup analyses, women with higher total calcium intake (diet plus supplements) at baseline were not at higher risk for coronary events (P=0.91 for interaction) or stroke (P=0.14 for interaction) if assigned to active calcium/vitamin D.
Conclusions Calcium/vitamin D supplementation neither increased nor decreased coronary or cerebrovascular risk in generally healthy postmenopausal women over a 7-year use period.
This article has been cited by other articles:
![]() |
S. C. Larsson, M. J. Virtanen, M. Mars, S. Mannisto, P. Pietinen, D. Albanes, and J. Virtamo Magnesium, Calcium, Potassium, and Sodium Intakes and Risk of Stroke in Male Smokers Arch Intern Med, March 10, 2008; 168(5): 459 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brown Combined hormone therapy 'increases risk of lobular breast cancer after just three years of use' Menopause Int, March 1, 2008; 14(1): 2 - 4. [Full Text] [PDF] |
||||
![]() |
M. Rees, J. Stevenson, and on behalf of the British Menopause Society Council Primary prevention of coronary heart disease in women Menopause Int, March 1, 2008; 14(1): 40 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Bolland, P A. Barber, R. N Doughty, B. Mason, A. Horne, R. Ames, G. D Gamble, A. Grey, and I. R Reid Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial BMJ, February 2, 2008; 336(7638): 262 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Howard and V. Feigin Advances in Population Studies 2007 Stroke, February 1, 2008; 39(2): 283 - 285. [Full Text] [PDF] |
||||
![]() |
T. J. Wang, M. J. Pencina, S. L. Booth, P. F. Jacques, E. Ingelsson, K. Lanier, E. J. Benjamin, R. B. D'Agostino, M. Wolf, and R. S. Vasan Vitamin D Deficiency and Risk of Cardiovascular Disease Circulation, January 29, 2008; 117(4): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lehman Evidently... Evid. Based Med., August 1, 2007; 12(4): 103 - 103. [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., August 1, 2007; 12(4): 127 - 128. [Full Text] [PDF] |
||||
![]() |
A. Zittermann, S. S. Schleithoff, and R. Koerfer Letter by Zitterman et al Regarding Article, "Calcium/Vitamin D Supplementation and Cardiovascular Events" Circulation, July 17, 2007; 116(3): e85 - e85. [Full Text] [PDF] |
||||
![]() |
D. E. Wallis and S. Penckofer Letter by Wallis and Penckofer Regarding Article, "Calcium/Vitamin D Supplementation and Cardiovascular Events" Circulation, July 17, 2007; 116(3): e86 - e86. [Full Text] [PDF] |
||||
![]() |
E. D. Michos and R. S. Blumenthal Vitamin D Supplementation and Cardiovascular Disease Risk Circulation, February 20, 2007; 115(7): 827 - 828. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |